Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Tetra borrowing $ from the Cellvera in Dubai India
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(58)
•••
Comment by SamV21on Sep 06, 2022 2:17pm
112 Views
Post# 34944509

RE:RE: Tetra borrowing $ from the Cellvera in Dubai India

RE:RE: Tetra borrowing $ from the Cellvera in Dubai India Funny paid basher , I haven't seen a penny for 4 years from this company that made promises of revenue since 2018 based on all the deals and connections they have , everyone know research takes money and invested into research not wages for a scammer that makes false promises and brings in hamburger flippers saying , its a 20.00 stock sucking people into the Tetra Bio scam.What happed to all the research and revenue promised on the eye cream, butt cream, skin cream and the Hemp Drink that was going to make revenue ? Then Panag Pharma was going to make us money in 2020 , selling Reduvo by the end of 2020 , the break out year . Wake up .
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities